Jan 14, 2010 · Taylor is a familiar figure at the FDA. He began his career as a staff attorney at the agency in 1976. Then he worked for a decade at King & Spaulding, which represented Monsanto Corp., the agribusiness giant that developed genetically engineered corn, soybeans and bovine growth hormone. ad_icon. He returned to the FDA in 1991 as deputy ...
Aug 14, 2009 · Michael Taylor: Monsanto's Man in the Obama Administration. OCA Editor's Note: Write President Obama to oppose the appointment of former Monsanto lobbyist Michael Taylor as a senior adviser to the Food and Drug Administration Commissioner on food safety. Michael R. Taylor's appointment by the Obama administration to the Food and Drug Administration (FDA) …
Oct 15, 2013 · That firm was counsel to Monsanto. Obama nominated Elena Kagan to the US Supreme Court. Kagan, as federal solicitor general, had previously argued for Monsanto in the Monsanto v. Geertson seed case before the Supreme Court. The deck was stacked. Obama hadn’t simply made honest mistakes. Obama hadn’t just failed to exercise proper oversight in …
Jan 15, 2010 · With big changes to the nation's food safety system looming in 2010, the FDA made a strange move earlier this week when it appointed former Monsanto lobbyist Michael Taylor to lead the agency's ...
Employment HistoryPeriodEmployer1996-2000Monsanto Co Revolving Door Personnel: (20)1994-1996Food Safety & Inspection Service Revolving Door Personnel: (8)1991-1994Food & Drug Administration Revolving Door Personnel: (82)1981-1991King & Spalding Revolving Door Personnel: (60)8 more rows
Robert M. Califf M.D. was named Commissioner of Food and Drugs on February 17, 2022.Feb 17, 2022
Jacqueline Corrigan-Curay, J.D., M.D., is the Principal Deputy Center Director in FDA's Center for Drug Evaluation and Research (CDER).Feb 10, 2022
Scott GottliebIn office May 11, 2017 – April 5, 2019PresidentDonald TrumpDeputyAnna AbramPreceded byRobert Califf10 more rows
Michael R. TaylorMichael R. Taylor in 2009NationalityAmericanOccupationDeputy Commissioner for Foods, Food and Drug Administration
Janet Woodcock M.D. Leadership Role. Principal Deputy Commissioner - Office of the Commissioner. Janet Woodcock M.D.Feb 17, 2022
Robert Califf, MDThe Senate has confirmed Robert Califf, MD, as the next FDA commissioner. The Senate narrowly confirmed Dr. Califf's nomination by a 50-46 vote Feb. 15, giving the agency its first permanent leader in more than a year, according to The New York Times.Feb 16, 2022
Dr. Robert CaliffIncumbent. Dr. Robert Califf The United States Commissioner of Food and Drugs is the head of the Food and Drug Administration (FDA), an agency of the United States Department of Health and Human Services. The commissioner is appointed by the president of the United States and must be confirmed by the Senate.
Under the selective radar of mainstream media, Barack Obama has been carving out a whole new level of support for Monsanto and other destructive biotech giants.
Under the selective radar of mainstream media, Barack Obama has been carving out a whole new level of support for Monsanto and other destructive biotech giants.
On Tuesday, Pres. Obama inked his name to H.R. 933, a continuing resolution spending bill approved in Congress days earlier. Buried 78 pages within the bill exists a provision that grossly protects biotech corporations such as the Missouri-based Monsanto Company from litigation.
Obama signs 'Monsanto Protection Act' written by Monsanto-sponsored senator. United States President Barack Obama has signed a bill into law that was written in part by the very billion-dollar corporation that will benefit directly from the legislation.
1.) “The ‘Monsanto Protection Act’ effectively bars federal courts from being able to halt the sale or planting of controversial genetically modified (aka GMO) or genetically engineered (GE) seeds, no matter what health issues may arise concerning GMOs in the future.” (Studies have revealed severe adverse health effects related to the consumption of genetically modified foods.)
HR 933 was a spending bill aimed at averting a government shutdown.